Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer

BACKGROUND: Immune checkpoint inhibitors have dramatically changed lung cancer treatment, demonstrating an overall survival benefit. There are limited data about re-challenge in patients with non-small cell lung cancer. We attempted to address this question for re-challenge of immune checkpoint inhi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Niki, Maiko, Nakaya, Aya, Kurata, Takayasu, Yoshioka, Hiroshige, Kaneda, Toshihiko, Kibata, Kayoko, Ogata, Makoto, Nomura, Shosaku
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2018
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6122346/
https://ncbi.nlm.nih.gov/pubmed/30190787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25949
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky